Several analysts have recently updated their ratings and price targets for Cinemark (NYSE: CNK):
- 10/23/2026 – Cinemark had its “buy” rating reaffirmed by Roth Capital. They now have a $45.00 price target on the stock.
- 10/23/2026 – Cinemark had its price target raised by JPMorgan Chase & Co. from $39.00 to $41.00. They now have a “neutral” rating on the stock.
- 10/19/2026 – Cinemark had its “neutral” rating reaffirmed by B. Riley Financial.
- 10/13/2026 – Cinemark was upgraded by Zacks Research from “hold” to “strong-buy”.
- 10/8/2026 – Cinemark was upgraded by Weiss Ratings from “buy (b-)” to “buy (b)”.
- 9/24/2026 – Cinemark had its price target lowered by Morgan Stanley from $42.00 to $40.00. They now have an “equal weight” rating on the stock.
- 9/2/2026 – Cinemark was downgraded by Zacks Research from “strong-buy” to “hold”.
- 8/29/2026 – Cinemark was downgraded by Wall Street Zen from “strong-buy” to “buy”.
Cinemark Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 9th. Investors of record on Wednesday, August 26th were paid a dividend of $0.09 per share. The ex-dividend date was Wednesday, August 26th. This represents a $0.36 annualized dividend and a yield of 0.9%. Cinemark’s dividend payout ratio is 21.30%.
Cinemark Holdings, Inc (NYSE: CNK) is a leading motion picture exhibition company that operates movie theaters in the United States and Latin America. Through its Cinemark and Century theater brands, the company provides audiences with theatrical entertainment, including first-run films, premium large-format presentations and enhanced viewing experiences.
Cinemark’s theaters generate revenue primarily through ticket sales and food and beverage concessions. Its offerings may include reserved seating, luxury reclining seats, Cinemark XD premium auditoriums, online and mobile ticketing, and loyalty programs such as Cinemark Movie Rewards.
Featured Articles
- Five stocks we like better than Cinemark
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Cinemark Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cinemark Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.
